IBB News 223.35 05/09/2014 05:05:17 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 223.35 $IBB

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.82%
Comtex SmarTrend(R) - Thu May 08, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.82%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Thu May 08, 3:49PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - Zacks Investment Research - Mon May 05, 1:49AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day

'Fast Money' Recap: The Problem With Growth Stocks
at The Street - Tue Apr 29, 4:00AM CDT
The trading panel wonders why Facebook is having a good quarter when Google has been selling off.

Pharma ETFs: A Safe Haven from the Biotech Stock Slump? - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Apr 28, 10:42AM CDT
Why investors may want to think about a play on the pharmaceutical ETFs if they want drug industry exposure.

iShares Nasdaq Biotechnology Index Falls 2.46% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Apr 25, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $223.43 to a high of $229.28. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $223.61 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.46% Loss
Comtex SmarTrend(R) - Fri Apr 25, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $223.43 to a high of $229.28. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $223.61 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Celgene Beats on First-Quarter Earnings: What's Next?
George Budwell, The Motley Fool - Motley Fool - Thu Apr 24, 1:30PM CDT
Source: www.fiercepharma.com. Celgene Corporation    is the second-largest component of the  iShares Nasdaq Biotech Index  . As such, its 14% plus nosedive year to date has undoubtedly played a role in driving this key biotech index lower for...

Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:00AM CDT
Solid results from Gilead, but poor results from Amgen, look to have a big impact on these health care ETFs.

Pharma ETFs: A Better Healthcare Investment? - Video Blog
Eric Dutram - Zacks Investment Research - Wed Apr 23, 5:42PM CDT
How have pharma ETFs held up during the biotech selloff?

iShares Nasdaq Biotechnology Index Fund (IBB) : Buy @ $231.17
Trading Central - Tue Apr 22, 8:43AM CDT
From a technical view, the ETF is bouncing off a key rising trend line drawn from the bottom of October 2012. Regarding technical indicators, the weekly RSI is pushing above its 50 mark while the 20-week moving average is reversing up. On a...

'Fast Money' Recap: Following the Netflix Story
at The Street - Tue Apr 22, 4:00AM CDT
The trading panel discussed Netflix earnings and Valeant's hostile bid for Allergan.

What to Watch for in Biotech Earnings This Week
George Budwell, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Biotech stocks started the year off on a tear but have moved lower lately in dramatic fashion. For instance, the iShares Nasdaq Biotech Index is now down over 2% for the year, after gaining double digits at one point in early February. Pundits and...

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.33%
Comtex SmarTrend(R) - Mon Apr 21, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $221.37 to a high of $227.34. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $226.39 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist
George Budwell, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
The ongoing market correction has taken a serious toll on biotech stocks, especially among companies early in their development. The iShares Nasdaq Biotech Index , for instance, is down over 15% in the past month alone. Market corrections (and bull...

'Fast Money' Recap: Watch Where Bonds Are Headed
at The Street - Fri Apr 18, 4:00AM CDT
The trading panel discussed bonds, industrial stocks, Chipotle Mexican Grill and IBM.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 0

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 0

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 4

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 3

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 4

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 3

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 1

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 1

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 4

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 2

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Qualcomm and Apollo Consider Bold Move for Intel Amid Market Challenges

Updated Category News Views 104

Qualcomm and Apollo's Interest in Intel Qualcomm Inc. (NASDAQ: QCOM) is reportedly considering a potential acquisition of Intel Corp. (NASDAQ: INTC). This strategic move could greatly diversify Qualcomm’s range of products. While there's excitement about the prospect of this acquisition, analysts warn that several challenges might complicate the process. The State of...

Continue Reading
Biofuel Additives Market Growth to USD 32.39 Billion

Updated Category News Views 69

Biofuel Additives Market Size and Growth Recent research indicates that the demand for biofuel additives is set to reach USD 32.39 billion by 2032, with a compound annual growth rate (CAGR) of 8.89% during the forecast period. Key Factors Driving Market Growth The increasing emphasis on energy security, coupled with heightened environmental awareness, has significantly...

Continue Reading
Acumen Pharmaceuticals Advances Alzheimer's Research with Sabirnetug

Updated Category News Views 135

Acumen Pharmaceuticals Advances Alzheimer's Research Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) is making significant strides in the fight against Alzheimer’s disease (AD) through its innovative therapeutic approaches. The company is currently focused on its clinical development program for sabirnetug, a humanized monoclonal antibody designed to target toxic soluble...

Continue Reading
Used Cars Market Poised for Massive Growth by 2033

Updated Category News Views 68

Growth Projections for the Used Cars Market The Used Cars Market is currently experiencing a significant transformation. Projections suggest it will soar to an impressive USD 3.4 trillion by 2033. This figure represents a remarkable increase, bolstered by a strong compound annual growth rate (CAGR) of 7.3% from 2024 to 2033, as reported by Dimension Market Research....

Continue Reading
Topgolf Callaway Brands Unveils Its Latest Sustainability Efforts

Updated Category News Views 583

Topgolf Callaway Brands Releases Its Sustainability Report Topgolf Callaway Brands (NYSE: MODG) recently published its 2022-2023 Sustainability Report, highlighting the company's commitment to creating a positive environmental and social impact. This report showcases the progress made since the inaugural release, focusing on the areas of People, Planet, Product, and...

Continue Reading